Complete Genomics Inc Asset Turnover Ratio (GNOM), as of third quarter 2012, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Complete Genomics Inc  (GNOM)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Complete Genomics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Complete Genomics Inc asset turnover ratio, the ability of Complete Genomics Inc's assets to generate revenue in the third quarter 2012, increased sequentially to 0.21 in the third quarter (Sep 30 2012), a new company high.

Within sector 18 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2012 compared to the preceding quarter from 0 to 2892.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GNOM Asset Turnover Ratio (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter
Y / Y Asset Change -44.71 % -43.14 % 10.2 % - -
Y / Y Revenue Change 74.19 % 48.22 % -42.81 % -40.66 % 283.56 %
Asset Turnover Ratio (TTM) 0.21 0.16 0.12 0.14 0.2
GNOM's Total Ranking # 2892 # 0 # 0 # 0 #
Seq. Asset Change -15.23 % -15.97 % -13 % -10.79 % -12.81 %
Seq. Revenue Change -16.3 % 122.44 % 58.28 % -40.89 % -28.78 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Laboratories Industry # 19
Healthcare Sector # 272
Overall Market # 2892

Asset Turnover Ratio Statistics
High Average Low
0.21 0.19 0.16
(Sep 30 2012)   (Jun 30 2012)




GNOM Company Profile • Back to GNOM Efficiency Comparisons • Compare GNOM Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2012, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2012 Assets at quarter ending Sep 30 2012
Rti Surgical Holdings Inc   0.76 $ 176.437  Millions$ 232.830  Millions
Infusystem Holdings Inc  0.75 $ 56.637  Millions$ 75.160  Millions
Acorda Therapeutics Inc   0.75 $ 296.985  Millions$ 394.762  Millions
Regeneron Pharmaceuticals Inc   0.75 $ 1,086.852  Millions$ 1,447.964  Millions
Bard C R Inc  0.75 $ 2,947.400  Millions$ 3,933.550  Millions
Insite Vision Inc  0.75 $ 19.359  Millions$ 25.977  Millions
Pressure Biosciences Inc   0.74 $ 1.358  Millions$ 1.842  Millions
Baxter International Inc   0.74 $ 14,031.000  Millions$ 19,032.000  Millions
Haemonetics Corporation  0.73 $ 772.483  Millions$ 1,051.237  Millions
Orthofix Medical Inc   0.73 $ 443.221  Millions$ 603.750  Millions
Charles River Laboratories International inc   0.73 $ 1,140.352  Millions$ 1,556.842  Millions
Conmed Corporation  0.72 $ 751.473  Millions$ 1,040.543  Millions
Vertex Pharmaceuticals Inc  0.71 $ 1,756.388  Millions$ 2,468.451  Millions
Aim Immunotech Inc   0.71 $ 31.257  Millions$ 43.984  Millions
Agilent Technologies inc   0.71 $ 6,858.000  Millions$ 9,701.250  Millions
Integra Lifesciences Holdings Corp  0.71 $ 819.962  Millions$ 1,162.451  Millions
Vbi Vaccines Inc  0.71 $ 10.970  Millions$ 15.555  Millions
Akorn Inc  0.70 $ 227.263  Millions$ 323.387  Millions
Bolt Biotherapeutics Inc   0.70 $ 57.306  Millions$ 81.648  Millions
Atrion Corporation  0.70 $ 116.084  Millions$ 166.239  Millions
Becton Dickinson And Company  0.70 $ 7,826.164  Millions$ 11,248.632  Millions
Dyax Corp  0.69 $ 47.136  Millions$ 68.112  Millions
Luminex Corporation  0.69 $ 194.916  Millions$ 281.742  Millions
China Biologic Products Holdings Inc   0.69 $ 186.470  Millions$ 270.136  Millions
Incyte Corporation  0.69 $ 212.102  Millions$ 307.765  Millions
Eli Lilly And Company  0.69 $ 22,692.600  Millions$ 33,007.900  Millions
Resmed Inc   0.68 $ 1,393.472  Millions$ 2,034.442  Millions
Stryker Corp  0.68 $ 8,534.000  Millions$ 12,475.750  Millions
Ironwood Pharmaceuticals inc   0.68 $ 155.419  Millions$ 228.334  Millions
Endologix Inc  0.68 $ 100.116  Millions$ 147.685  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.